Methylphenidate and amantadine to stimulate reawakening in comatose patients resuscitated from cardiac arrest

Resuscitation

Volumn 84, Issue 6, 2013, Pages 818-824

  Reynolds, Joshua C ^a   Rittenberger, Jon C ^a   Callaway, Clifton W ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Amantadine; Cardiac arrest; Coma; Methylphenidate; Resuscitation

Indexed keywords

AMANTADINE; METHYLPHENIDATE;

ADVERSE OUTCOME; AROUSAL; ARTICLE; CLINICAL ARTICLE; COMA; ELECTROENCEPHALOGRAM; FEMALE; HEART ARREST; HUMAN; MALE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; RESUSCITATION; TREATMENT OUTCOME;

ADULT; AGED; AMANTADINE; CARDIOPULMONARY RESUSCITATION; CENTRAL NERVOUS SYSTEM STIMULANTS; COHORT STUDIES; COMA; FEMALE; HEART ARREST; HUMANS; MALE; METHYLPHENIDATE; MIDDLE AGED; PATIENT DISCHARGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84879885689     PISSN: 03009572     EISSN: 18731570     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2012.11.014     Document Type: Article

References (34)

1. Neumar R.W., Nolan J.P., Adrie C., et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation 2008, 118:2452-2483.
2. Reynolds J.C., Lawner B.J. Management of the post-cardiac arrest syndrome. J Emerg Med 2012, [Epub ahead of print].
3. Sunde K., Pytte M., Jacobsen D., et al. Implementation of a standardised treatment protocol for post-resuscitation care after out-of-hospital cardiac arrest. Resuscitation 2007, 73:29.
4. Rittenberger J.C., Guyette F.X., Tisherman S.A., DeVita M.A., Alvarez R.J., Callaway C.W. Outcomes of a hospital-wide plan to improve care of comatose survivors of cardiac arrest. Resuscitation 2008, 79:198.
5. Laver S., Farrow C., Turner D., Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med 2004, 30:2126.
6. Volkow N., Wang G., Fowler J., et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiat 1998, 155:1325-1331.
7. Whyte J., Hart T., Vaccaro M., et al. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. Am J Phys Med Rehabil 2004, 83:401-420.
8. Moein H., Khalili H.A., Keramatian K. Effect of methylphenidate on ICU and hospital length of stay in patients with severe and moderate traumatic brain injury. Clin Neurol Neurosurg 2006, 108:539-542.
9. Plenger P.M., Dixon C.E., Castillo R.M., Frankowski R.F., Yablon S.A., Levin H.S. Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Arch Phys Med Rehabil 1996, 77:536-540.
10. Sawyer E., Mauro L.S., Ohlinger M.J. Amantadine enhancement of arousal and cognition after traumatic brain injury. Ann Pharmacother 2008, 42:247-252.
11. DeMarchi R., Bansal V., Hung A., et al. Review of awakening agents. Can J Neurol Sci 2005, 32:4-17.
12. Hughes S., Colantonio A., Santaguida P.L., Paton T. Amantadine to enhance readiness for rehabilitation following severe traumatic brain injury. Brain Injury 2005, 19:1197-1206.
13. Saniova B., Drobny M., Kneslova L., Minarik M. The outcome of patients with severe head injuries treated with amantadine sulphate. J Neural Transm 2004, 111:511-514.
14. Whyte J., Katz D., Long D., et al. Predictors of outcome in prolonged posttraumatic disorders of consciousness and assessment of medication effects: a multicenter study. Arch Phys Med Rehabil 2005, 86:453-462.
15. Patrick P.D., Blackman J.A., Mabry J.L., Buck M.L., Gurka M.J., Conaway M.R. Dopamine agonist therapy in low-response children following traumatic brain injury. J Child Neurol 2006, 21:879-885.
16. Meythaler J.M., Brunner R.C., Johnson A., Novack T.A. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil 2002, 17:300-313.
17. Giacino J.T., Whyte J., Bagiella E., et al. Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med 2012, 366:819-826.
18. Donnino M.W., Rittenberger J.C., Gaieski D., et al. The development and implementation of cardiac arrest centers. Resuscitation 2011, 82:974.
19. Teasdale G., Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974, 2:81-84.
20. Wijdicks E.F., Bamlet W.R., Maramattom B.V., Manno E.M., McClelland R.L. Validation of a new coma scale: the FOUR score. Ann Neurol 2005, 58:585-593.
21. Rittenberger J.C., Tisherman S.A., Holm M.B., Guyette F.X., Callaway C.W. An early, novel illness severity score to predict outcome after cardiac arrest. Resuscitation 2011, 82:1399-1404.
22. Cummins R.O., Chamberlain D.A., Abramson N.S., et al. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the utstein style. A statement for health professionals from a task force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council. Circulation 1991, 84:960-975.
23. van Swieten J.C., Koudstaal P.J., Visser M.C., Schouten H.J., van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988, 19:604-607.
24. Rittenberger J.C., Popescu A., Guyette F.X., Callaway C.W. Frequency timing of nonconvulsive status epilepticus in comatose post-cardiac arrest subjects treated with hypothermia. Neurocrit Care 2012, 16:114-122. PMCID:PMC3188346.
25. Peberdy M.A., Callaway C.W., Neumar R.W., et al. Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010, 122:S768.
26. Wu O., Sorensen A.G., Benner T., Singhal A.B., Furie K.L., Greer D.M. Comatose patients with cardiac arrest: predicting clinical outcome with diffusion-weighted MR imaging. Radiology 2009, 252:173-181.
27. Rittenberger J.C., Sangl J., Wheeler M., Guyette F.X., Callaway C.W. Association between clinical examination and outcome after cardiac arrest. Resuscitation 2010, 81:1128.
28. Metter R.B., Ritenberger J.C., Guyette F.X., Callaway C.W. Association between initial CT scan of brain and outcome after cardiac arrest. Resuscitation 2011, 82:1180-1185.
29. Canal Castro C., Pagnussat A.S., Orlandi L., et al. Coumestrol has neuroprotective effects before and after global cerebral ischemia in female rats. Brain Res 2012, 1474:82-90.
30. Taguchi N., Nakayama S., Tanaka M. Fluoxetine has neuroprotective effects after cardiac arrest and cardiopulmonary resuscitation in mouse. Resuscitation 2012, 83:652-656.
31. Kelley M.H., Kuroiwa M., Taguchi N., Herson P.S. Sex difference in sensitivity to allopregnanolone neuroprotection in mice correlates with effect on spontaneous inhibitory post synaptic currents. Neuropharmacology 2011, 61:724-729.
32. Quintard H., Borsotto M., Veyssiere J., et al. MLC901, a traditional Chinese medicine protects the brain against global ischemia. Neuropharmacology 2011, 61:622-631.
33. Yang Z.J., Ni X., Carter E.L., Kibler K., Martin L.J., Koehler R.C. Neuroprotective effect of acid-sensing ion channel inhibitor psalmotoxin-1 after hypoxia-ischemia in newborn piglet striatum. Neurobiol Dis 2011, 43:446-454.
34. Knapp J., Heinzmann A., Schneider A., et al. Hypothermia and neuroprotection by sulfide after cardiac arrest and cardiopulmonary resuscitation. Resuscitation 2011, 82:1076-1080.